Published in Schizophr Bull on January 16, 2008
The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder. Neuropsychopharmacology (2011) 1.07
Evidence of IQ-modulated association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients. Neuropsychopharmacology (2012) 0.95
COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation. J Psychiatry Neurosci (2013) 0.93
COMT and ALDH2 polymorphisms moderate associations of implicit drinking motives with alcohol use. Addict Biol (2011) 0.87
Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J Neural Transm (Vienna) (2011) 0.86
COMT Val158Met polymorphism, cognitive stability and cognitive flexibility: an experimental examination. Behav Brain Funct (2010) 0.84
Neural correlates of the attention network test in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2011) 0.82
Executive attention impairment in first-episode schizophrenia. BMC Psychiatry (2012) 0.81
Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype. BMC Psychiatry (2013) 0.80
Differential impairments across attentional networks in binge drinking. Psychopharmacology (Berl) (2017) 0.76
Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults. Sci Rep (2015) 0.76
Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia. PLoS One (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci (2000) 18.84
The attention system of the human brain. Annu Rev Neurosci (1990) 15.51
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Testing the efficiency and independence of attentional networks. J Cogn Neurosci (2002) 8.03
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet (2004) 5.70
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature (1995) 5.63
The activation of attentional networks. Neuroimage (2005) 5.61
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
Development of attentional networks in childhood. Neuropsychologia (2004) 4.81
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry (2002) 4.51
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A (2003) 4.21
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience (1991) 4.05
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A (1998) 3.99
Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry (1991) 3.88
Schizophrenia and velo-cardio-facial syndrome. Lancet (2002) 3.88
The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl (1989) 3.61
The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology (2004) 3.51
Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry (2006) 3.24
Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry (2003) 3.12
Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1990) 3.07
D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev (2000) 2.95
What does the PANSS mean? Schizophr Res (2005) 2.86
Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry (2003) 2.82
Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biol Psychiatry (2003) 2.78
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry (2000) 2.62
The development of executive attention: contributions to the emergence of self-regulation. Dev Neuropsychol (2005) 2.53
A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry (2002) 2.51
Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev (2000) 2.51
Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry (2004) 2.41
Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci (2005) 2.37
Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci (2004) 2.35
Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22
Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull (1994) 2.18
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) (2004) 2.06
Assessing the molecular genetics of attention networks. BMC Neurosci (2002) 2.02
Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand (1995) 1.97
Assessing the heritability of attentional networks. BMC Neurosci (2001) 1.81
Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol (1999) 1.70
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry (2002) 1.66
Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry (2004) 1.54
Brain regions underlying response inhibition and interference monitoring and suppression. Eur J Neurosci (2006) 1.51
Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berl) (2001) 1.44
Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry (2004) 1.29
Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: tuning rather than improving performance. Am J Psychiatry (2005) 1.23
Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology (2003) 1.19
Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neuroscience (2006) 1.19
Attentional networks and cingulum bundle in chronic schizophrenia. Schizophr Res (2006) 1.18
Selective impairment of attentional networks of orienting and executive control in schizophrenia. Schizophr Res (2005) 1.17
Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res (1997) 1.17
The mechanism of action of novel antipsychotic drugs. Schizophr Bull (1991) 1.14
The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry (1999) 1.09
Anterior cingulate cortex activation during cognitive interference in schizophrenia. Am J Psychiatry (2004) 1.08
Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett (1998) 1.06
Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet (2002) 1.04
The "benefits" of distractibility: mechanisms underlying increased Stroop effects in schizophrenia. Schizophr Bull (1999) 1.02
Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry (2003) 1.02
Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry (1998) 1.02
Antipsychotic efficacy: relationship to optimal D2-receptor occupancy. Eur Psychiatry (2007) 0.97
Factors influencing Stroop performance in schizophrenia. Neuropsychology (2004) 0.95
Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study. J Psychiatr Res (2006) 0.93
Cognitive deficits and the neurobiology of schizophrenia. Curr Opin Neurobiol (1995) 0.89
The Stroop effect in schizophrenic patients. Schizophr Res (1996) 0.88
Cognitive control and semantics in schizophrenia: an integrated approach. Am J Psychiatry (2005) 0.88
Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet B Neuropsychiatr Genet (2003) 0.87
Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication. Psychiatry Res (1996) 0.83
Re-examining sustained attention deficits as vulnerability indicators for schizophrenia: stability in the long term course. J Psychiatr Res (2006) 0.80
15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet (2009) 6.21
Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain (2009) 3.96
Retracted Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet (2003) 2.70
Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis. Psychiatr Genet (2006) 2.50
Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet (2009) 2.12
A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol (2002) 1.77
Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet (2012) 1.48
Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci (2008) 1.41
CLCN2 variants in idiopathic generalized epilepsy. Nat Genet (2009) 1.26
DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol (2014) 1.21
Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. J Clin Psychiatry (2010) 1.16
Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department. Alcohol Clin Exp Res (2004) 1.12
Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage (2008) 1.12
Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy. Ann Neurol (2014) 1.11
Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09
Comparison of ligand- and structure-based virtual screening on the DUD data set. J Chem Inf Model (2009) 1.08
Exploration of the genetic architecture of idiopathic generalized epilepsies. Epilepsia (2006) 1.07
Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. Epilepsia (2013) 1.07
Allelic association of a truncation mutation of the KCNMB3 gene with idiopathic generalized epilepsy. Am J Med Genet B Neuropsychiatr Genet (2007) 1.06
Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice. Am J Hum Genet (2007) 1.06
Gender-dependent association of the functional catechol-O-methyltransferase Val158Met genotype with sensation seeking personality trait. Neuropsychopharmacology (2007) 1.05
KIBRA and CLSTN2 polymorphisms exert interactive effects on human episodic memory. Neuropsychologia (2009) 1.04
Event-related potentials associated with Attention Network Test. Int J Psychophysiol (2010) 1.03
Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry (2003) 1.02
Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy. Epilepsia (2013) 0.99
A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy. Epilepsia (2007) 0.98
Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. Neuropsychopharmacology (2006) 0.97
Association of attentional network function with exon 5 variations of the CHRNA4 gene. Hum Mol Genet (2007) 0.97
Pregabalin versus pramipexole for restless legs syndrome. N Engl J Med (2014) 0.96
RBFOX1 and RBFOX3 mutations in rolandic epilepsy. PLoS One (2013) 0.95
Clozapine-induced agranulocytosis and its genetic determinants. Pharmacogenomics (2008) 0.95
Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. Epilepsia (2012) 0.94
The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol Dis (2005) 0.94
Feasible and successful: genome-wide interaction analysis involving all 1.9 x 10(11) pair-wise interaction tests. Hum Hered (2010) 0.93
Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study. J Psychiatr Res (2006) 0.93
Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache (2006) 0.92
Mutations in FKBP10 can cause a severe form of isolated Osteogenesis imperfecta. BMC Med Genet (2011) 0.92
Genetic dissection of photosensitivity and its relation to idiopathic generalized epilepsy. Ann Neurol (2005) 0.91
A new EF-hand containing gene EFHC2 on Xp11.4: tentative evidence for association with juvenile myoclonic epilepsy. Epilepsy Res (2005) 0.91
Ebbinghaus revisited: influences of the BDNF Val66Met polymorphism on backward serial recall are modulated by human aging. J Cogn Neurosci (2010) 0.90
Association of CYP2D6 genotypes and personality traits in healthy individuals. J Clin Psychopharmacol (2006) 0.90
Absence seizures with intellectual disability as a phenotype of the 15q13.3 microdeletion syndrome. Epilepsia (2011) 0.90
Association of BRD2 polymorphisms with photoparoxysmal response. Neurosci Lett (2006) 0.90
Correlation of self-assessed fatigue and alertness in multiple sclerosis. Mult Scler (2010) 0.89
EXOSC3 mutations in isolated cerebellar hypoplasia and spinal anterior horn involvement. J Neurol (2013) 0.89
Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage (2009) 0.88
Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics (2010) 0.88
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis. J Clin Psychopharmacol (2004) 0.87
Toxicity-indicating structural patterns. J Chem Inf Model (2006) 0.87
Neonatal seizures with tonic clonic sequences and poor developmental outcome. Epilepsy Res (2005) 0.87
Attention Network Test reveals alerting network dysfunction in multiple sclerosis. Mult Scler (2009) 0.86
Linkage and association analysis of CACNG3 in childhood absence epilepsy. Eur J Hum Genet (2007) 0.86
Mutation analysis of the hyperpolarization-activated cyclic nucleotide-gated channels HCN1 and HCN2 in idiopathic generalized epilepsy. Neurobiol Dis (2007) 0.86
Linkage and mutational analysis of CLCN2 in childhood absence epilepsy. Epilepsy Res (2007) 0.86
Evaluation of CACNA1H in European patients with childhood absence epilepsy. Epilepsy Res (2006) 0.86
Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology (2002) 0.86
Evidence of specificity of a visual P3 amplitude modulation deficit in schizophrenia. Schizophr Res (2010) 0.85
Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits. Neurosci Lett (2008) 0.85
A duplication in 1q21.3 in a family with early onset and childhood absence epilepsy. Epilepsia (2010) 0.85
Single-subject classification of schizophrenia by event-related potentials during selective attention. Neuroimage (2010) 0.84
Genome wide high density SNP-based linkage analysis of childhood absence epilepsy identifies a susceptibility locus on chromosome 3p23-p14. Epilepsy Res (2009) 0.84
Tandem pore domain K(+)-channel TASK-3 (KCNK9) and idiopathic absence epilepsies. Am J Med Genet (2002) 0.84
Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia. Psychiatry Res (2009) 0.84
Variant GADL1 and response to lithium in bipolar I disorder. N Engl J Med (2014) 0.84
Association analysis of exonic variants of the GABA(B)-receptor gene and alpha electroencephalogram voltage in normal subjects and alcohol-dependent patients. Behav Genet (2003) 0.83
Linkage analysis between childhood absence epilepsy and genes encoding GABAA and GABAB receptors, voltage-dependent calcium channels, and the ECA1 region on chromosome 8q. Epilepsy Res (2002) 0.83
Confirmatory evidence for an association of the connexin-36 gene with juvenile myoclonic epilepsy. Epilepsy Res (2006) 0.83
Analysis of ELP4, SRPX2, and interacting genes in typical and atypical rolandic epilepsy. Epilepsia (2014) 0.82
Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility. J Chem Inf Model (2008) 0.82
COMT Val108/158Met genotype modulates human sensory gating. Neuroimage (2010) 0.82
Effects of smoking history on selective attention in schizophrenia. Neuropharmacology (2012) 0.82
Eosinophilia indicating subclinical clozapine-induced pericarditis. J Clin Psychiatry (2007) 0.81
Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens. Eur Arch Psychiatry Clin Neurosci (2004) 0.81
TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue. Seizure (2013) 0.81
Role of GRM4 in idiopathic generalized epilepsies analysed by genetic association and sequence analysis. Epilepsy Res (2010) 0.81
Association of EEG coherence and an exonic GABA(B)R1 gene polymorphism. Am J Med Genet B Neuropsychiatr Genet (2003) 0.81
Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J Cogn Neurosci (2007) 0.81
Myofibrillogenesis regulator 1 gene (MR-1) mutation in an Omani family with paroxysmal nonkinesigenic dyskinesia. Neurosci Lett (2006) 0.81
Circulating microRNAs as biomarkers for detection of autologous blood transfusion. PLoS One (2013) 0.81
Sequencing of the GRIK1 gene in patients with juvenile absence epilepsy does not reveal mutations affecting receptor structure. Am J Med Genet (2002) 0.80
Flow cytometric assessment of erythrocyte shape through analysis of FSC histograms: use of kurtosis and implications for longitudinal evaluation. PLoS One (2013) 0.80
Association between dopamine D4 receptor genotype and trait impulsiveness. Psychiatr Genet (2014) 0.80
Candidate gene analysis of the succinic semialdehyde dehydrogenase gene (ALDH5A1) in patients with idiopathic generalized epilepsy and photosensitivity. Neurosci Lett (2006) 0.80